Wellstat Diagnostics, LLC - Product Pipeline Analysis, 2015 Update

Date: December 9, 2015
Pages: 16
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: W931CF48EFFEN
Leaflet:

Download PDF Leaflet

Wellstat Diagnostics, LLC - Product Pipeline Analysis, 2015 Update
SUMMARY

Wellstat Diagnostics, LLC (Wellstat Diagnostics) is a medical equipment company that develops, manufactures, sells, and distributes point of care diagnostic systems. The company develops products by using electrochemiluminescence technology, which is suited for the immunodiagnostic and nucleic acid testing market segments of the clinical testing market. Its product conduct assays in various types including immunoassays, enzymatic activity assays, binding assays and nucleic acid detection assays, among others. The company offers its system to test patient samples to measure the presence of disease and monitor medical conditions. Wellstat Diagnostics is headquartered in Gaithersburg, Maryland, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

SCOPE:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Wellstat Diagnostics, LLC
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
REASONS TO BUY:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Wellstat Diagnostics, LLC Company Snapshot
Wellstat Diagnostics, LLC Company Overview
Key Information
Wellstat Diagnostics, LLC Pipeline Products and Clinical Trials Overview
Wellstat Diagnostics, LLC - Major Products and Services
Wellstat Diagnostics, LLC Pipeline Products by Development Stage
Wellstat Diagnostics, LLC Pipeline Products Overview
Electrochemiluminescent Based RNA Detection Platform
Electrochemiluminescent Based RNA Detection Platform Product Overview
Rapid Point-Of-Care Blood-Based Diagnostic Test - Lyme Disease
Rapid Point-Of-Care Blood-Based Diagnostic Test - Lyme Disease Product Overview
Rapid Point-Of-Care Blood-Based Diagnostic Test - Non Alcoholic Fatty Liver Disease
Rapid Point-Of-Care Blood-Based Diagnostic Test - Non Alcoholic Fatty Liver Disease Product Overview
Wellstat Diagnostics, LLC - Key Competitors
Wellstat Diagnostics, LLC - Locations And Subsidiaries
Head Office
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Wellstat Diagnostics, LLC, Key Facts
Wellstat Diagnostics, LLC Pipeline Products and Clinical Trials Overview
Wellstat Diagnostics, LLC Pipeline Products by Equipment Type
Wellstat Diagnostics, LLC Pipeline Products by Indication
Wellstat Diagnostics, LLC, Major Products and Services
Wellstat Diagnostics, LLC Number of Pipeline Products by Development Stage
Wellstat Diagnostics, LLC Pipeline Products Summary by Development Stage
Electrochemiluminescent Based RNA Detection Platform - Product Status
Electrochemiluminescent Based RNA Detection Platform - Product Description
Rapid Point-Of-Care Blood-Based Diagnostic Test - Lyme Disease - Product Status
Rapid Point-Of-Care Blood-Based Diagnostic Test - Lyme Disease - Product Description
Rapid Point-Of-Care Blood-Based Diagnostic Test - Non Alcoholic Fatty Liver Disease - Product Status
Rapid Point-Of-Care Blood-Based Diagnostic Test - Non Alcoholic Fatty Liver Disease - Product Description

LIST OF FIGURES

Wellstat Diagnostics, LLC Pipeline Products by Equipment Type
Wellstat Diagnostics, LLC Pipeline Products by Development Stage
Skip to top


Ask Your Question

Wellstat Diagnostics, LLC - Product Pipeline Analysis, 2015 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: